Form 4: Theravance Biopharma CFO Reports Stock Transaction
Insider Transaction (Form 4)
Aziz Sawaf, SVP & CHIEF FINANCIAL OFFICER of Theravance Biopharma, Inc., reported a transaction in 8,112 shares of common stock on August 20, 2026.
Summary
- Tax/exercise-price withholding: disposed of 8,112 Ordinary Shares at $16.95 ($137,498) on August 20, 2026; holds 336,841 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Aziz Sawaf — Officer (SVP & CHIEF FINANCIAL OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-20 | Tax/exercise-price withholding | Ordinary Shares | 8,112 | $17 | $137.5K | 336,841 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-20 | Tax/exercise-price withholding (8,112 shares) |
Keywords
insider transaction, Form 4, TBPH, Theravance Biopharma, Inc., neutral, Aziz Sawaf
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.